FR2615393A1 - Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine - Google Patents

Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine Download PDF

Info

Publication number
FR2615393A1
FR2615393A1 FR8806725A FR8806725A FR2615393A1 FR 2615393 A1 FR2615393 A1 FR 2615393A1 FR 8806725 A FR8806725 A FR 8806725A FR 8806725 A FR8806725 A FR 8806725A FR 2615393 A1 FR2615393 A1 FR 2615393A1
Authority
FR
France
Prior art keywords
triazine
amino
nicotinoylamino
nootropic agent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8806725A
Other languages
English (en)
French (fr)
Inventor
Kiyoshi Kimura
Fusao Ueda
Masaru Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of FR2615393A1 publication Critical patent/FR2615393A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8806725A 1987-05-20 1988-05-19 Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine Withdrawn FR2615393A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12462587 1987-05-20

Publications (1)

Publication Number Publication Date
FR2615393A1 true FR2615393A1 (fr) 1988-11-25

Family

ID=14890046

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8806725A Withdrawn FR2615393A1 (fr) 1987-05-20 1988-05-19 Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine

Country Status (5)

Country Link
US (1) US4874762A (enrdf_load_stackoverflow)
DE (1) DE3816937A1 (enrdf_load_stackoverflow)
FR (1) FR2615393A1 (enrdf_load_stackoverflow)
GB (1) GB2204791B (enrdf_load_stackoverflow)
IT (1) IT1219594B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55147278A (en) * 1980-04-21 1980-11-17 Nippon Shinyaku Co Ltd Nicotinoylaminotriazine derivative
JPS5735587A (en) * 1980-06-04 1982-02-26 Nippon Shinyaku Co Ltd Benzoguanamine derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52118483A (en) * 1976-03-29 1977-10-04 Nippon Shinyaku Co Ltd Nicotinylaminotriazine derivatives
JPS59106473A (ja) * 1982-12-10 1984-06-20 Nippon Shinyaku Co Ltd トリアジン誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55147278A (en) * 1980-04-21 1980-11-17 Nippon Shinyaku Co Ltd Nicotinoylaminotriazine derivative
JPS5735587A (en) * 1980-06-04 1982-02-26 Nippon Shinyaku Co Ltd Benzoguanamine derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, vol. 5, no. 20 (C-42)[692], 6 février 1981; & JP-A-55 147 278 (NIPPON SHINYAKU K.K.) 17-11-1980 *
PATENT ABSTRACTS OF JAPAN, vol. 6, no. 106 (C-108)[984], 16 juin 1982; & JP-A-57 035 587 (NIPPON SHINYAKU K.K.) 26-02-1982 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
GB2204791B (en) 1990-09-26
IT1219594B (it) 1990-05-18
GB8811364D0 (en) 1988-06-15
DE3816937C2 (enrdf_load_stackoverflow) 1991-03-14
GB2204791A (en) 1988-11-23
IT8847980A0 (it) 1988-05-18
DE3816937A1 (de) 1988-12-08
US4874762A (en) 1989-10-17

Similar Documents

Publication Publication Date Title
HU221014B1 (hu) 2-Amino-6-(n-propil-amino)-4,5,6,7-tetrahidrobenztiazol alkalmazása depresszió kezelésére használható gyógyszerkészítmény előállítására
FR2642759A1 (fr) Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
JPH0733332B2 (ja) 痴呆症状改善・治療剤
EP0527081B1 (fr) Nouvelles pipérazinylalcoyl-3 dihydro-2,3 4H-benzoxazine-1,3 ones-4 substituées, leur préparation et leur application en thérapeutique
EP0429360B1 (fr) Inhibition du syndrome d'abstinence
CN100502847C (zh) 含有取代喹啉和取代二苯砜的组合物及其制药用途
FR2533563A1 (fr) Nouveaux derives de la sulfonyluree, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2615393A1 (fr) Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine
HUP0401967A2 (hu) Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására
FR2721825A1 (fr) Compositions pharmaceutiques et procede permettant leur preparation
FR2615392A1 (fr) Agent nootrope a base de 2,4-diamino-6-alcoxyphenyl-s-triazine
US4029807A (en) Compounds 5-hydroxytryptophan glutamate and its derivatives
US3467755A (en) Compositions and methods for producing sedation and tranquilization with substituted 4,5,6,7- tetrahydro-4-oxindoles
EP1175215A2 (fr) L'osanetant dans le traitement des troubles de l'humeur
US4621101A (en) Pharmaceutical compositions with antianginal activity
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
FR2681322A1 (fr) Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
BE1003959A5 (fr) Agent therapeutique pour le traitement de troubles associes a l'ischemie cerebrale.
KR950011409B1 (ko) 히드록시인돌 유도체
WO1995003801A1 (fr) Antidepressif
EP1569642B1 (fr) Utilisation de la canthin-6-one, des extraits de plantes la contenant et de ses derives dans le traitement des trypanosomiases
FR2691630A1 (fr) Composition pharmaceutique, en particulier pour l'administration orale, contenant, comme ingrédient actif, un agoniste sélectif des récepteurs de type 5HT1.
JPH11512705A (ja) チック症を処置する方法
FR2738818A1 (fr) Nouveaux derives d'oxydation d'indolylalkylamines, et leur utilisation a titre de medicament
JPH03271223A (ja) ナフトキサジン類の新用途

Legal Events

Date Code Title Description
ST Notification of lapse